°æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Oral Solid Dosage Contract Manufacturing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»óǰÄÚµå : 1679137
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 173 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,227,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,555,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 12,291,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Persistence Market Research´Â ÃÖ±Ù ¼¼°è °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, ÃËÁø¿äÀÎ, µµÀü °úÁ¦ µî Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ°í ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ º¸°í¼­´Â 2025³âºÎÅÍ 2032³â±îÁö ¼¼°è °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀåÀÇ ¿¹Ãø ¼ºÀå ±ËÀûÀ» °³°ýÇÏ´Â µ¶Á¡ÀûÀÎ µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

°æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå - Á¶»ç ¹üÀ§:

Á¤Á¦, ĸ½¶, ¼ÒÇÁÆ®Á©°ú °°Àº °æ±¸ °íÇüÁ¦Á¦´Â Á¦¾à»ê¾÷¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀåÀº ÀÌ·¯ÇÑ Á¦Á¦ÀÇ ½ÃÀå °³Ã´ ¹× Á¦Á¶¸¦ Àü¹®À¸·Î ÇÏ´Â Á¦¾àȸ»ç¿¡ À§Å¹»ý»ê ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº Á¦³×¸¯ Á¦¾à»ç, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, ÀǾàǰ °³¹ß ¼öʱâ°ü(CRO)ÀÇ ¿ä±¸¿¡ ºÎÀÀÇÏ¿© Á¦Á¦ °³¹ß, ±ÔÁ¦ ´ëÀÀ, ´ë±Ô¸ð »ý»ê¿¡ ´ëÇÑ Àü¹® Áö½ÄÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº °æ±¸¿ë °íÇü Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ºñ¿ë È¿À²ÀûÀÎ Á¦Á¶ ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½É Áõ°¡ÀÔ´Ï´Ù.

½ÃÀå ÃËÁø¿äÀÎ:

¼¼°è °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀåÀº Á¦Á¶ ºñ¿ë Àý°¨°ú ¾÷¹« È¿À²¼º Çâ»óÀ» À§ÇÑ Á¦¾à»çµéÀÇ ¾Æ¿ô¼Ò½Ì µµÀÔ Áõ°¡ µî ¸î °¡Áö ÁÖ¿ä ¿äÀο¡ ÈûÀÔ¾î ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Á¦¾à ¾÷°è´Â °í·ÉÈ­ Ãß¼¼¿¡ µû¸¥ ¼ö¿ä¿¡ ´ëÀÀÇØ¾ß ÇÏ´Â »óȲ¿¡¼­ Á¦Á¶ ¾Æ¿ô¼Ò½ÌÀ» ÅëÇØ ±â¾÷Àº ¿¬±¸°³¹ß µî ÇÙ½É ¿ª·®¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦³×¸¯ ÀǾàǰ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, °íǰÁúÀÇ ºñ¿ë È¿À²ÀûÀÎ °æ±¸ °íÇüÁ¦ Á¦Á¶ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¿¬¼Ó »ý»ê ¹× ÷´Ü ÄÚÆÃ ±â¼ú°ú °°Àº Á¦Á¶ ±â¼úÀÇ ¹ßÀüÀ¸·Î Á¦Á¶ °øÁ¤ÀÇ È¿À²¼º°ú ǰÁúÀÌ Çâ»óµÇ¾î ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¾ïÁ¦¿äÀÎ:

À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀåÀº ±ÔÁ¦ Áؼö, ÁöÀûÀç»ê±Ç º¸È£, º¯µ¿ÇÏ´Â ¿øÀÚÀç ºñ¿ë°ú °ü·ÃµÈ µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀǾàǰ Á¦Á¶ ¹× ½ÂÀο¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀº ½Å±Ô ÁøÀÔ ±â¾÷¿¡°Ô Å« ÁøÀÔÀ庮À¸·Î ÀÛ¿ëÇÏ¿© ¿î¿µ ºñ¿ëÀ» Áõ°¡½Ãŵ´Ï´Ù. ¶ÇÇÑ, µ¶Á¡Àû Á¦Çü ¹× ±â¼ú º¸È£¿Í °°Àº ÁöÀûÀç»ê±Ç ¹®Á¦´Â Áö¼ÓÀûÀÎ ¸®½ºÅ©°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿øÀÚÀç °¡°Ý »ó½Â°ú °ø±Þ¸Á È¥¶õÀº ƯÈ÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ °³¹ßµµ»ó±¹¿¡¼­´Â À§Å¹»ý»ê ±â¾÷ÀÇ ¼öÀͼº¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

°æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀåÀº °íǰÁúÀÇ Àú·ÅÇÑ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Á¦¾à ¾÷°èÀÇ ¾Æ¿ô¼Ò½ÌÀ¸·ÎÀÇ ÀüȯÀ¸·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ Áõ°¡¿Í °í·ÉÈ­¿¡ µû¶ó Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ½Å·ÚÇÒ ¼ö ÀÖ´Â À§Å¹ Á¦Á¶ ¼­ºñ½º¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ÂÃãÇü ÀÇ·áÀÇ ¹ßÀü°ú ½Å¾à °³¹ßÀº À§Å¹»ý»ê ±â¾÷¿¡°Ô Çõ½ÅÀûÀÎ ½ÃÀå ¿ä±¸¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, ÷´Ü ¼³ºñ ÅõÀÚ, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼­ºñ½º È®´ë°¡ ÇâÈÄ ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

Á¦4Àå ¼¼°èÀÇ °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå Àü¸Á:

Á¦5Àå ¼¼°èÀÇ °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå Àü¸Á : Áö¿ª

Á¦6Àå ºÏ¹ÌÀÇ °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå Àü¸Á:

Á¦7Àå À¯·´ÀÇ °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå Àü¸Á:

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå Àü¸Á:

Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå Àü¸Á:

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå Àü¸Á:

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °æ±¸ °íÇüÁ¦ À§Å¹»ý»ê ½ÃÀå Àü¸Á:

Á¦12Àå °æÀï ±¸µµ

Á¦13Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the worldwide market for oral solid dosage contract manufacturing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global oral solid dosage contract manufacturing market from 2025 to 2032.

Key Insights:

Oral Solid Dosage Contract Manufacturing Market - Report Scope:

Oral solid dosage forms, such as tablets, capsules, and soft gels, play a vital role in the pharmaceutical industry. The oral solid dosage contract manufacturing market offers outsourced production services to pharmaceutical companies that specialize in the development and production of these dosage forms. The market serves the needs of generic drug manufacturers, biotechnology companies, and contract research organizations (CROs), providing them with expertise in formulation development, regulatory compliance, and large-scale production. Market growth is driven by an increasing demand for oral solid dosage forms, the rising prevalence of chronic diseases, and the growing focus on cost-effective manufacturing solutions.

Market Growth Drivers:

The global oral solid dosage contract manufacturing market is propelled by several key factors, including the increasing adoption of outsourcing among pharmaceutical companies looking to reduce production costs and enhance operational efficiency. As the pharmaceutical industry faces growing pressure to meet the demands of a larger, aging population, the outsourcing of manufacturing allows companies to focus on their core competencies, such as research and development. Furthermore, the demand for generic drugs and biosimilars is expected to increase, further fueling the need for high-quality, cost-effective oral solid dosage manufacturing services. Additionally, advancements in manufacturing technologies, such as continuous manufacturing and advanced coating techniques, are improving the efficiency and quality of production processes, fostering market growth.

Market Restraints:

Despite the promising growth prospects, the oral solid dosage contract manufacturing market faces challenges related to regulatory compliance, intellectual property protection, and fluctuating raw material costs. Stringent regulatory requirements governing the manufacturing and approval of pharmaceutical products create significant barriers to entry for new market players and increase operational costs. Furthermore, issues related to intellectual property, such as the protection of proprietary formulations and technologies, present ongoing risks. In addition, rising raw material prices and supply chain disruptions can impact the profitability of contract manufacturers, particularly in developing regions where resources may be limited.

Market Opportunities:

The oral solid dosage contract manufacturing market presents significant growth opportunities driven by the increasing demand for high-quality, affordable medicines and the ongoing shift toward outsourcing in the pharmaceutical industry. With the rise in chronic diseases and the aging population, there is an expanding market for generic drugs, creating a need for reliable contract manufacturing services. Moreover, advancements in personalized medicine and the development of new drug formulations offer opportunities for contract manufacturers to innovate and cater to evolving market needs. Strategic partnerships, investments in state-of-the-art facilities, and the expansion of services in emerging markets will be key drivers of future growth.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading players in the global oral solid dosage contract manufacturing market, including Lonza Group, Catalent, Inc., and Samsung Biologics, focus on expanding their manufacturing capabilities and service offerings to meet the diverse needs of pharmaceutical companies. These companies invest in the development of state-of-the-art manufacturing facilities, enhancing their ability to produce a wide range of oral solid dosage forms, including tablets, capsules, and controlled-release formulations. Moreover, they are actively engaged in strategic partnerships, acquisitions, and collaborations with pharmaceutical companies and research institutions to enhance their market position and drive innovation.

Key Companies Profiled:

Oral Solid Dosage Contract Manufacturing Market Segmentation

By Dosage Form

By Mechanism

By Application

By End User

By Region

Table of Contents

1. Executive Summary

2. Market Overview

3. Value Added Insights

4. Global Oral Solid Dosage Contract Manufacturing Market Outlook:

5. Global Oral Solid Dosage Contract Manufacturing Market Outlook: Region

6. North America Oral Solid Dosage Contract Manufacturing Market Outlook:

7. Europe Oral Solid Dosage Contract Manufacturing Market Outlook:

8. East Asia Oral Solid Dosage Contract Manufacturing Market Outlook:

9. South Asia & Oceania Oral Solid Dosage Contract Manufacturing Market Outlook:

10. Latin America Oral Solid Dosage Contract Manufacturing Market Outlook:

11. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Outlook:

12. Competition Landscape

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â